BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kumari N, Choi SH. Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies. J Exp Clin Cancer Res 2022;41. [DOI: 10.1186/s13046-022-02272-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Feng Y, Liao Z, Zhang H, Xie X, You F, Liao X, Wu C, Zhang W, Yang H, Liu Y. Emerging nanomedicines strategies focused on tumor microenvironment against cancer recurrence and metastasis. Chemical Engineering Journal 2023;452:139506. [DOI: 10.1016/j.cej.2022.139506] [Reference Citation Analysis]
2 Chatziioannou E, Aydin SA, Forchhammer S, Sinnberg T, Eigentler T. Makrophagen im Melanom – von molekularen Signalen zur therapeutischen Anwendung. Dermatologie 2022. [DOI: 10.1007/s00105-022-05077-3] [Reference Citation Analysis]
3 Barsheshet Y, Voloshin T, Brant B, Cohen G, Koren L, Blatt R, Cahal S, Haj Khalil T, Zemer Tov E, Paz R, Klein-goldberg A, Tempel-brami C, Jacobovitch S, Volodin A, Kan T, Koltun B, David C, Haber A, Giladi M, Weinberg U, Palti Y. Tumor Treating Fields (TTFields) Concomitant with Immune Checkpoint Inhibitors Are Therapeutically Effective in Non-Small Cell Lung Cancer (NSCLC) In Vivo Model. IJMS 2022;23:14073. [DOI: 10.3390/ijms232214073] [Reference Citation Analysis]
4 Gao J, Zhao Z, Zhang H, Huang S, Xu M, Pan H. Transcriptomic characterization and construction of M2 macrophage-related prognostic and immunotherapeutic signature in ovarian metastasis of gastric cancer. Cancer Immunol Immunother 2022. [DOI: 10.1007/s00262-022-03316-z] [Reference Citation Analysis]
5 Zeng J, Sun Y, Sun S, Jiang M, Zhang D, Li W, Liu Z, Shang H, Guan X, Zhang W. Leveraging Nanodrug Delivery System for Simultaneously Targeting Tumor Cells and M2 Tumor-Associated Macrophages for Efficient Colon Cancer Therapy. ACS Appl Mater Interfaces 2022. [DOI: 10.1021/acsami.2c11534] [Reference Citation Analysis]
6 Peng H, He X, Wang Q. Targeted drug delivery system for ovarian cancer microenvironment: Improving the effects of immunotherapy. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1035997] [Reference Citation Analysis]
7 Talib WH, Abuawad A, Thiab S, Alshweiat A, Mahmod AI. Flavonoid-based nanomedicines to target tumor microenvironment. OpenNano 2022;8:100081. [DOI: 10.1016/j.onano.2022.100081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Yaping W, Zhe W, Zhuling C, Ruolei L, Pengyu F, Lili G, Cheng J, Bo Z, Liuyin L, Guangdong H, Yaoling W, Niuniu H, Rui L. The soldiers needed to be awakened: Tumor-infiltrating immune cells. Front Genet 2022;13:988703. [DOI: 10.3389/fgene.2022.988703] [Reference Citation Analysis]
9 Zhao B, Li X, Kong Y, Wang W, Wen T, Zhang Y, Deng Z, Chen Y, Zheng X. Recent advances in nano-drug delivery systems for synergistic antitumor immunotherapy. Front Bioeng Biotechnol 2022;10:1010724. [DOI: 10.3389/fbioe.2022.1010724] [Reference Citation Analysis]
10 Feng J, Ren J, Li X, Zhang X, Yang Q, Wu Z, Cui L, Liao L, Gong Y, Cao D. Phagocytosis-Regulators-Based Signature to Predict the Prognosis and Chemotherapy Resistance for Breast Cancer Patients. IJMS 2022;23:10312. [DOI: 10.3390/ijms231810312] [Reference Citation Analysis]
11 Wang J, Wang X, Yang K, Hu S, Wang W. Self-Assembly of Small Organic Molecules into Luminophores for Cancer Theranostic Applications. Biosensors 2022;12:683. [DOI: 10.3390/bios12090683] [Reference Citation Analysis]
12 Aramini B, Masciale V, Samarelli AV, Dubini A, Gaudio M, Stella F, Morandi U, Dominici M, De Biasi S, Gibellini L, Cossarizza A. Phenotypic, functional, and metabolic heterogeneity of immune cells infiltrating non–small cell lung cancer. Front Immunol 2022;13:959114. [DOI: 10.3389/fimmu.2022.959114] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Guan M, Wang M, Wang W, Li C, Yao L, Zhu H, Yang T. Exosomes as mediators of tumor immune escape and immunotherapy in hepatocellular carcinoma. Liver Research 2022. [DOI: 10.1016/j.livres.2022.08.001] [Reference Citation Analysis]
14 Chen G, Yang F, Fan S, Jin H, Liao K, Li X, Liu G, Liang J, Zhang J, Xu J, Pi J. Immunomodulatory roles of selenium nanoparticles: Novel arts for potential immunotherapy strategy development. Front Immunol 2022;13:956181. [DOI: 10.3389/fimmu.2022.956181] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Park K, Ahn JW, Kim JH, Kim JW. Tumor-associated macrophage-targeted photodynamic cancer therapy using a dextran sulfate-based nano-photosensitizer. Int J Biol Macromol 2022;218:384-93. [PMID: 35902009 DOI: 10.1016/j.ijbiomac.2022.07.159] [Reference Citation Analysis]
16 Ling J, Chang Y, Yuan Z, Chen Q, He L, Chen T. Designing Lactate Dehydrogenase-Mimicking SnSe Nanosheets To Reprogram Tumor-Associated Macrophages for Potentiation of Photothermal Immunotherapy. ACS Appl Mater Interfaces 2022;14:27651-65. [PMID: 35675569 DOI: 10.1021/acsami.2c05533] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Anang V, Singh A, Kottarath SK, Verma C. Receptors of immune cells mediates recognition for tumors. Progress in Molecular Biology and Translational Science 2022. [DOI: 10.1016/bs.pmbts.2022.09.009] [Reference Citation Analysis]